Literature DB >> 30267461

Antihypertensive treatment and renal protection: Is there a J-curve relationship?

Francesca Viazzi1, Giovanna Leoncini1, Guido Grassi2,3, Roberto Pontremoli1.   

Abstract

A bidirectional relationship between hypertension and kidney disease, with one exacerbating the effect of the other, is well established. Elevated blood pressure (BP) is a well-recognized, modifiable risk factor for cardiovascular (CV) disease as well as for development and progression of chronic kidney disease and, therefore, the identification of optimal BP target is a key issue in the management of renal patients. Recent large trials and real life cohort studies have indicated that below a definite BP value renal protection seems to plateau and too low levels may even be associated with a paradoxical increase in renal morbidity, thus reviving the debate about the so called BP -renal function J-curve relationship. Existing evidence supports a systolic target around 130 mm Hg to combine both renal and CV protection and possibly lower levels in the presence of overt proteinuria. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  J-curve relationship; RAAS-inhibition; albuminuria; chronic kidney disease; glomerular filtration rate; hypertension; target blood pressure

Mesh:

Substances:

Year:  2018        PMID: 30267461      PMCID: PMC8030923          DOI: 10.1111/jch.13396

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  75 in total

1.  Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Iryna Lobach; Franz H Messerli
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.

Authors:  Alan S Go; Mary Ann Bauman; Sallyann M Coleman King; Gregg C Fonarow; Willie Lawrence; Kim A Williams; Eduardo Sanchez
Journal:  Hypertension       Date:  2013-11-15       Impact factor: 10.190

3.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Giacomina Loriga; Maria Ganeva; Bogdan Ene-Iordache; Marta Turturro; Maria Lesti; Elena Perticucci; Ivan Nediyalkov Chakarski; Daniela Leonardis; Giovanni Garini; Adalberto Sessa; Carlo Basile; Mirella Alpa; Renzo Scanziani; Gianbattista Sorba; Carmine Zoccali; Giuseppe Remuzzi
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

Review 4.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

Review 5.  Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Authors:  Ausilia Maione; Sankar D Navaneethan; Giusi Graziano; Ruth Mitchell; David Johnson; Johannes F E Mann; Peggy Gao; Jonathan C Craig; Giovanni Tognoni; Vlado Perkovic; Antonio Nicolucci; Salvatore De Cosmo; Antonio Sasso; Olga Lamacchia; Mauro Cignarelli; Valeria Maria Manfreda; Giorgio Gentile; Giovanni F M Strippoli
Journal:  Nephrol Dial Transplant       Date:  2011-03-03       Impact factor: 5.992

6.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

Authors:  George L Bakris; Rajiv Agarwal; Juliana C Chan; Mark E Cooper; Ron T Gansevoort; Hermann Haller; Giuseppe Remuzzi; Peter Rossing; Roland E Schmieder; Christina Nowack; Peter Kolkhof; Amer Joseph; Alexander Pieper; Nina Kimmeskamp-Kirschbaum; Luis M Ruilope
Journal:  JAMA       Date:  2015-09-01       Impact factor: 56.272

8.  Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.

Authors:  Francesca Viazzi; Eulalia Greco; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Pietro Guida; Giuseppina Russo; Salvatore De Cosmo; Roberto Pontremoli
Journal:  Kidney Blood Press Res       Date:  2018-03-16       Impact factor: 2.687

9.  Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.

Authors:  Morten Schmidt; Kathryn E Mansfield; Krishnan Bhaskaran; Dorothea Nitsch; Henrik Toft Sørensen; Liam Smeeth; Laurie A Tomlinson
Journal:  BMJ       Date:  2017-03-09

10.  Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

Authors:  Srinivasan Beddhu; Michael V Rocco; Robert Toto; Timothy E Craven; Tom Greene; Udayan Bhatt; Alfred K Cheung; Debbie Cohen; Barry I Freedman; Amret T Hawfield; Anthony A Killeen; Paul L Kimmel; James Lash; Vasilios Papademetriou; Mahboob Rahman; Anjay Rastogi; Karen Servilla; Raymond R Townsend; Barry Wall; Paul K Whelton
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391

View more
  6 in total

1.  Chronic kidney disease in low-middle income populations: a call to action for screening and prevention.

Authors:  Anna Paini; Massimo Salvetti; Silvio Caligaris; Francesco Castelli; Maria Lorenza Muiesan
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

2.  Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics.

Authors:  Roberto Minutolo; Luca De Nicola; Ciro Gallo; Paolo Chiodini; Michele Provenzano; Giuseppe Conte; Carlo Garofalo; Silvio Borrelli
Journal:  J Nephrol       Date:  2019-01-23       Impact factor: 3.902

Review 3.  Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Authors:  Giuliano Tocci; Barbara Citoni; Vivianne Presta; Giovanna Leoncini; Francesca Viazzi; Barbara Bonino; Massimo Volpe; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2019-12-21       Impact factor: 3.397

Review 4.  Antihypertensive treatment and renal protection: Is there a J-curve relationship?

Authors:  Francesca Viazzi; Giovanna Leoncini; Guido Grassi; Roberto Pontremoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-28       Impact factor: 3.738

5.  The influence of blood pressure patterns on renal outcomes in patients with chronic kidney disease: The long-term follow up result of the APrODiTe-2 study.

Authors:  Ran-Hui Cha; Hajeong Lee; Jung Pyo Lee; Yon Su Kim; Sung Gyun Kim
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

6.  Factors Associated with Visit-to-Visit Variability of Blood Pressure Measured as Part of Routine Clinical Care among Patients Attending Cardiology Outpatient Department of a Tertiary Care Centre in Northern Sri Lanka.

Authors:  Thirunavukarasu Kumanan; Vathulan Sujanitha; Mahesan Guruparan; Nadarajah Rajeshkannan
Journal:  Int J Hypertens       Date:  2019-12-05       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.